Loading
IT
iCo Therapeutics Inc. Stock: price and insider trades · Canada
iCo Therapeutics Inc.: what insiders have been doing
Every trade that managers of iCo Therapeutics Inc. disclose to SEDI is tracked on this page. iCo Therapeutics Inc. has had no insider filing for more than a year; the last one goes back to 24 September 2020.
Since 2016, the database holds 15 purchases and no sales by insiders of the company.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
15
Thresholds
n/a
Buy Volume
€131,877
15 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 24 September 2020
Declarations15 total
272,000 shares@ CA$0.0349Common SharesTSXSEDI:3605497
Canonical exit: 21 Dec 2020 (T+90)
50,000 shares@ CA$0.035Common SharesTSXSEDI:3605499
Canonical exit: 21 Dec 2020 (T+90)
235,000 shares@ CA$0.0349Common SharesTSXSEDI:3605498
Canonical exit: 21 Dec 2020 (T+90)
273,556 shares@ CA$0.35Common SharesTSXSEDI:3601348
Canonical exit: 10 Dec 2020 (T+90)
450,000 shares@ CA$0.03527.8% of flowCommon SharesTSXSEDI:3186793
Canonical exit: 20 Aug 2018 (T+90)
250,000 shares@ CA$0.03515.5% of flowCommon SharesTSXSEDI:3186798
Canonical exit: 21 Aug 2018 (T+90)
500,000 shares@ CA$0.03530.8% of flowCommon SharesTSXSEDI:3186789
Canonical exit: 16 Aug 2018 (T+90)
400,000 shares@ CA$0.03525.9% of flowCommon SharesTSXSEDI:2863694
Canonical exit: 4 Oct 2016 (T+90)
148,000 shares@ CA$0.046.5% of flowCommon SharesTSXSEDI:2785971
Canonical exit: 10 May 2016 (T+90)
45,000 shares@ CA$0.0351.7% of flowCommon SharesTSXSEDI:2785040
Canonical exit: 9 May 2016 (T+90)
57,000 shares@ CA$0.0352.2% of flowCommon SharesTSXSEDI:2785037
Canonical exit: 8 May 2016 (T+90)
47,000 shares@ CA$0.031.6% of flowCommon SharesTSXSEDI:2777149
Canonical exit: 21 Apr 2016 (T+90)
203,000 shares@ CA$0.036.9% of flowCommon SharesTSXSEDI:2777154
Canonical exit: 24 Apr 2016 (T+90)
9,000 shares@ CA$0.0250.2% of flowCommon SharesTSXSEDI:2775813
Canonical exit: 19 Apr 2016 (T+90)
491,000 shares@ CA$0.0316.1% of flowCommon SharesTSXSEDI:2775811
Canonical exit: 20 Apr 2016 (T+90)
15 of 15 declarations
About iCo Therapeutics Inc.
iCo Therapeutics Inc. is a biopharmaceutical company focused on developing treatments for ocular diseases and infections. It is listed on the Toronto Stock Exchange under the symbol XTSE.
